|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.380
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.332
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.306
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.208
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.206
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.193
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.171
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.169
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.162
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.147
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.142
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.135
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.132
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.122
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.119
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.117
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.115
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.113
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.110
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.104
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.102
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.102
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.100
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.096
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.095
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.089
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.088
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.087
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.086
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.086
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.084
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.083
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.082
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.082
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.081
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.081
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.080
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.080
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.079
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.079
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.077
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.073
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.072
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.070
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.068
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.067
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.067
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.066
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.065
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.065
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.065
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.064
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.064
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.063
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.063
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.063
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.061
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.061
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.061
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.061
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.061
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.060
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.060
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.060
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.060
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.059
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.059
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.058
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.058
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.057
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.057
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.055
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.055
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.055
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.054
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.054
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.054
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.053
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.053
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.052
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.052
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.052
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.052
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.051
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.050
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.050
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.050
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.050
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.050
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.049
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.049
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.049
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.049
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.049
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.048
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.048
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.048
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.048
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.048
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.048
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.047
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.047
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.047
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.047
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.046
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.046
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.046
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.046
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.046
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.046
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.046
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.046
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.045
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.045
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.045
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.044
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.044
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.044
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.043
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.043
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.042
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.042
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.042
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.042
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.042
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.041
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.041
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.041
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.041
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.041
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.041
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.041
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.040
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.040
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.040
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.040
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.040
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.040
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.040
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.040
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.040
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.040
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.040
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.040
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.040
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.040
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.039
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.039
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.039
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.039
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.039
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.039
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.039
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.039
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.038
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.038
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.038
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.038
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.038
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.038
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.037
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.037
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.037
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.037
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.037
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.037
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.037
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.037
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.036
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.036
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.036
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.036
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.036
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.036
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.036
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.036
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.036
|
|
|
|
rap protein signal transduction
|
GO:0032486 |
3 |
0.035
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.035
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.035
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.035
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.035
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.034
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.034
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.034
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.034
|
|
|
|
post anal tail morphogenesis
|
GO:0036342 |
23 |
0.034
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.034
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.034
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.034
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.034
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.034
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.034
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.034
|
|
|
|
paraxial mesoderm development
|
GO:0048339 |
18 |
0.034
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.033
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.033
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.033
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.033
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.033
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.032
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.032
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.032
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.032
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.032
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.032
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.032
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.032
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.032
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.032
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.032
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.032
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.032
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.031
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.031
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.031
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.031
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.031
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.031
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.031
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.031
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.031
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.031
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.031
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.031
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.030
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.030
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.030
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.030
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.030
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.030
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.030
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.030
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.030
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.030
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.030
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.030
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.029
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.029
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.029
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.029
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.029
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.029
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.029
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.029
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.029
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.029
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.029
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.028
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.028
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.028
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.028
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.028
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.028
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.028
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.028
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.028
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.028
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.028
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.028
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.027
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.027
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.027
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.027
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.027
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.027
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.027
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.027
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.026
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.026
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.026
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.026
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.026
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.026
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.026
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.026
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.026
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.026
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.026
|
|
|
|
deltoid tuberosity development
|
GO:0035993 |
3 |
0.026
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.026
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.026
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.026
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.026
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.025
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.025
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.025
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.025
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.025
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.025
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.025
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.025
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.025
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.025
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.025
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.025
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.025
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.025
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.025
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.025
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.025
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.025
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.025
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.025
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.025
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.025
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.025
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.025
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.025
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.025
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.024
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.024
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.024
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.024
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.024
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.024
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.024
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.024
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.024
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.024
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.024
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.024
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.024
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.024
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.024
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.023
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.023
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.023
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.023
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.023
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.023
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.023
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.023
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.023
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.023
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.023
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.023
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.023
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.023
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.023
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.023
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.023
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.023
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.023
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.023
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.023
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.022
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.022
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.022
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.022
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.022
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.022
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.022
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.022
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
31 |
0.022
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.022
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.022
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.022
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.022
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.022
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.022
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.022
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.022
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.022
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.022
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.022
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.022
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.022
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.022
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.022
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.022
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.021
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.021
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.021
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.021
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.021
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.021
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.021
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.021
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.021
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.021
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.021
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.021
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.021
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.021
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.021
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.021
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.021
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.021
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.021
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.021
|
|
|
|
apoptotic process involved in development
|
GO:1902742 |
28 |
0.021
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.021
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.021
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.020
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.020
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.020
|
|
|
|
auditory receptor cell differentiation
|
GO:0042491 |
37 |
0.020
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.020
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.020
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.020
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.020
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.020
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.020
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.020
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.020
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.020
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.020
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.020
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.020
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.019
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.019
|
|
|
|
regulation of vascular wound healing
|
GO:0061043 |
2 |
0.019
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.019
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.019
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.019
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.019
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.019
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.019
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.019
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.019
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.019
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.019
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.019
|
|
|
|
positive regulation of semaphorin plexin signaling pathway
|
GO:2001262 |
1 |
0.019
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.019
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.019
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.019
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.019
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.019
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.019
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.019
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.018
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.018
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.018
|
|
|
|
positive regulation of transcription by glucose
|
GO:0046016 |
3 |
0.018
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.018
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.018
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.018
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.018
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.018
|
|
|
|
mesenchyme morphogenesis
|
GO:0072132 |
32 |
0.018
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.018
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.018
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.018
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.018
|
|
|
|
vascular wound healing
|
GO:0061042 |
3 |
0.018
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.018
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.018
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.018
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.018
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.018
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.018
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.018
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.018
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.018
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.018
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.018
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.018
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.018
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.018
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.018
|
|
|
|
neuron fate determination
|
GO:0048664 |
9 |
0.018
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.018
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.017
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.017
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.017
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.017
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.017
|
|
|
|
sensory organ boundary specification
|
GO:0008052 |
1 |
0.017
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.017
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.017
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.017
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.017
|
|
|
|
positive regulation of nuclear division
|
GO:0051785 |
27 |
0.017
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.017
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.017
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.017
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.017
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.017
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.017
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.017
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.017
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.017
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.017
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.017
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.017
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.017
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.017
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.016
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.016
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.016
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.016
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.016
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.016
|
|
